Stockholders approve asset sale to Ninjour Health and merger-related charter amendments

Vyome Holdings, Inc

Asset Sale to Ninjour Health International Ltd approved: 1,273,715 For, 26,206 Against, 2,305 Abstentions.
Charter amendment for Vyome Therapeutics merger approved: 1,240,191 For, 58,555 Against, 3,480 Abstentions.
Special Meeting reconvened on August 7, 2025 after adjournment on July 24, 2025 to vote on these proposals.
Amendments to Article VI of Restated Certificate of Incorporation will take effect at merger close.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.